Decision

Boehringer Ingelheim (Canada) Ltd. v. Canada (Health), 2024 FC 1766

Associate Justice Cotter - 2024-11-06

Read full decision. Generated by ChatGPT:

The court granted a motion by two respondents to strike the notice of application, ruling the applicant lacked standing. The notice sought to challenge a decision by the Minister of Health granting a generic drug company a notice of compliance for a drug equivalent to one marketed by the applicant. The applicant argued the Minister erred in issuing the notice without approving a lower strength for safety reasons. The court held that, for a motion to strike, facts in the notice are taken as true, and affidavit evidence is generally not admissible unless exceptional circumstances exist. One exception is when an affidavit appends a document referenced in the notice. The court emphasized that affidavits should not be used to supplement the grounds stated in the notice of application.

Decision relates to:

  • T-2108-23 - BOEHRINGER INGELHEIM(CANADA)LTD. v. THE MINISTER OF HEALTH ET AL.

 

Canadian Intellectual Property